TY - JOUR
T1 - Preventing transmission of multidrug-resistant bacteria in health care settings
T2 - A tale of two guidelines
AU - Strausbaugh, Larry J.
AU - Siegel, Jane D.
AU - Weinstein, Robert A.
PY - 2006/3/15
Y1 - 2006/3/15
N2 - Two guidelines for the control of multidrug-resistant organisms in health care facilities have appeared during the past 3 years-one from the Society for Healthcare Epidemiology of America and one, in draft form, from the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention. These guidelines reflect universal concern in the infection-control community about today's unprecedented levels of activity of multidrug-resistant organisms and about inadequate or inconsistent application of potentially effective control measures. The 2 guidelines provide detailed reviews of pertinent issues and evidence-based, rated recommendations, which overlap considerably. Recommendations regarding indications for active surveillance cultures and the extent of their use constitute the major divergence. Although implementation of comprehensive control plans for multidrug-resistant organisms advocated by both guidelines will require health care facilities to confront difficult programmatic issues, aggressive and widespread adoption of control measures for multidrug-resistant organisms is urgently needed.
AB - Two guidelines for the control of multidrug-resistant organisms in health care facilities have appeared during the past 3 years-one from the Society for Healthcare Epidemiology of America and one, in draft form, from the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention. These guidelines reflect universal concern in the infection-control community about today's unprecedented levels of activity of multidrug-resistant organisms and about inadequate or inconsistent application of potentially effective control measures. The 2 guidelines provide detailed reviews of pertinent issues and evidence-based, rated recommendations, which overlap considerably. Recommendations regarding indications for active surveillance cultures and the extent of their use constitute the major divergence. Although implementation of comprehensive control plans for multidrug-resistant organisms advocated by both guidelines will require health care facilities to confront difficult programmatic issues, aggressive and widespread adoption of control measures for multidrug-resistant organisms is urgently needed.
UR - http://www.scopus.com/inward/record.url?scp=33644836125&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644836125&partnerID=8YFLogxK
U2 - 10.1086/500408
DO - 10.1086/500408
M3 - Review article
C2 - 16477561
AN - SCOPUS:33644836125
SN - 1058-4838
VL - 42
SP - 828
EP - 835
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 6
ER -